Corteva, Inc. Common Stock CTVA
$12.57
-83.81%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (9 Buy · 4 Hold · 0 Sell)
- Average Price Target
- $93.08
- Implied Upside
- +640.5%
- Price Target Range
- $83.00 – $103.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-18 | Argus ResearchAlexandra Yates |
Reiterates | Buy | $91 |
| 2026-09-17 | CitigroupPatrick Cunningham |
Maintains | Neutral | $86 → $91 |
| 2026-09-16 | BMO CapitalJoel Jackson |
Maintains | Outperform | $100 → $95 |
| 2026-09-16 | UBSJoshua Spector |
Maintains | Neutral | $85 → $90 |
| 2026-09-16 | RBC CapitalArun Viswanathan |
Reiterates | Outperform | $103 |
| 2026-09-11 | KeybancSalvator Tiano |
Initiates coverage on | Sector weight | — |
| 2026-08-18 | UBSJoshua Spector |
Maintains | Neutral | $89 → $85 |
| 2026-08-03 | UBSJoshua Spector |
Maintains | Neutral | $86 → $89 |
| 2026-08-03 | CitigroupPatrick Cunningham |
Maintains | Neutral | $85 → $86 |
| 2026-08-03 | JP MorganJeffrey Zekauskas |
Maintains | Neutral | $77 → $83 |
| 2026-08-03 | BMO CapitalJoel Jackson |
Maintains | Outperform | $95 → $100 |
| 2026-07-23 | OppenheimerKristen Owen |
Maintains | Outperform | $89 → $95 |
| 2026-07-21 | RBC CapitalArun Viswanathan |
Maintains | Outperform | $97 → $103 |
| 2026-07-20 | B of A SecuritiesSteve Byrne |
Maintains | Buy | $90 → $96 |
| 2026-07-14 | MizuhoJohn Roberts |
Maintains | Outperform | $96 → $97 |
| 2026-07-02 | MizuhoJohn Roberts |
Maintains | Outperform | $94 → $96 |
| 2026-06-11 | BarclaysBenjamin Theurer |
Maintains | Overweight | $84 → $91 |
| 2026-06-09 | UBSJoshua Spector |
Maintains | Neutral | $90 → $86 |
| 2026-05-28 | Morgan StanleyVincent Andrews |
Maintains | Overweight | $84 → $95 |
| 2026-05-07 | UBSJoshua Spector |
Maintains | Neutral | $88 → $90 |
| 2026-05-07 | CitigroupPatrick Cunningham |
Maintains | Neutral | $83 → $85 |
| 2026-04-24 | RBC CapitalArun Viswanathan |
Maintains | Outperform | $89 → $95 |
| 2026-04-22 | OppenheimerKristen Owen |
Maintains | Outperform | $86 → $89 |
| 2026-04-21 | Wells FargoMichael Sison |
Maintains | Overweight | $85 → $90 |
| 2026-04-09 | UBSJoshua Spector |
Maintains | Neutral | $80 → $88 |
| 2026-03-31 | Argus ResearchBill Selesky |
Maintains | Buy | $80 → $91 |
| 2026-02-17 | MizuhoJohn Roberts |
Maintains | Outperform | $80 → $82 |
| 2026-02-05 | CitigroupPatrick Cunningham |
Maintains | Neutral | $74 → $80 |
| 2026-02-05 | RBC CapitalArun Viswanathan |
Maintains | Outperform | $80 → $89 |
| 2026-02-05 | Wells FargoMichael Sison |
Maintains | Overweight | $77 → $85 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $12.57
- Market Cap
- $8.39 billion
- 52-Week Range
- $11.84 – $90.97
- Average Volume
- 7.60 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.